Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|February 5, 2014
Prognostic impact of the inclusion of uPA/PAI-1 tumor levels in the current adjuvant treatment decision-making for early breast cancerHaïdar Saadoun, Pierre-Jean Lamy, Simon Thezenas, et al.
Annales De Biologie Clinique|January 31, 2017
Added value of hepcidin quantification for the diagnosis and follow-up of anemia-related diseasesThibaud Lefebvre, Sigismond Lasocki, Martine Fénéant-Thibault, et al.
Cancer Medicine|September 24, 2017
Nonsteroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk: results from the EPICAP studySolene Doat, Sylvie Cénée, Brigitte Trétarre, et al.
BMC Cancer|December 19, 2015
High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancersWilliam Jacot, Caroline Mollevi, Frédéric Fina, et al.
Clinical Breast Cancer|January 2, 2018
Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast CancerAkiko Chiba, Rachna Raman, Alexandra Thomas, et al.
International Journal of Cancer|April 27, 2018
Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP studySolène Doat, Miguelle Marous, Xavier Rebillard, et al.
Breast Cancer Research and Treatment|July 8, 2017
Prognostic impact of the inclusion of uPA/PAI-1 for adjuvant treatment decision-making in ER+/Her2- pN0 early breast cancersMarie Viala, Marie Alexandre, Simon Thezenas, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 8, 2024
Use of hospital big data to optimize and personalize laboratory test interpretation with an applicationRonan Boutin, Jakez Rolland, Marie Codet, et al.
BMC Cancer|November 7, 2013
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancerWilliam Jacot, Simon Thezenas, Romain Senal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatmentFlorence Boissière-Michot, Evelyne Lopez-Crapez, Hélène Frugier, et al.
Pageof 9